Presentation is loading. Please wait.

Presentation is loading. Please wait.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Mammalian Cells Bioreactor Market to reach $1.5 bn by 2024

Similar presentations


Presentation on theme: "© 2016 Global Market Insights, Inc. USA. All Rights Reserved Mammalian Cells Bioreactor Market to reach $1.5 bn by 2024"— Presentation transcript:

1 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024 Global Bioreactor Market forecast to exceed $1.9 billion by 2024: Global Market Insights Inc.

2 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Global Market Insights, Inc. says, the Global Bioreactor Industry is estimated to register 18% CAGR over the period of 2016-2024.  Growing focus on R&D in biotechnology and increasingly rising chronic disorders are outlined as the prime drivers behind bioreactors market growth.  The surging precision medicine market has impelled personalized medical treatments for the patients, which, in turn, will favor the growth of bioreactor industry.  Progressing tissue engineering technologies, development of orphan drugs, and growing antibodies production are also identified as the typical trends which are significantly driving the bioreactors market share.  Biopharma manufacturers, CMOs (Contract manufacturing organizations) and R&D organizations are the three predominant end-use industries in the worldwide bioreactor market.  The bioreactor industry is likely to spectate growing collaborations in biopharmaceutical sector through strategic partnerships with diagnostic developers, medical device manufacturers, and even academic institutions. Key Insights from Bioreactor Market:

3 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  One such example is of Sartorius Stedim Biotech, a leading global supplier in the biopharmaceutical industry acquisition of U.S. start-up kSep Holdings, Inc. in 2016.  kSep Systems leverages its innovation and engineering expertise to develop automated centrifugation systems which are widely used in manufacturing of monoclonal antibodies, cell- based therapeutics, and vaccines.  The growing number of pharmaceutical companies and technological advancements in the medical space is driving the U.S. bioreactor market size, slated to cross an industry valuation of USD 600 million by 2024.  Based on technology, bioreactor market is segmented into single use bubble column, wave- induced motion SUB, and stirred SUB technology.  China bioreactor industry driven by rising prevalence of chronic diseases and increasing R&D investment in the region is further expected to record an annual growth rate of 19% over the time span of 2016-2024.  Eppendorf, Sartorius, GE Healthcare, Thermo Fisher Scientific, and Merck Millipore are some of the prominent players in bioreactor industry. Continued...

4 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com U.S. Bioreactor Market Share, By Technology, 2016

5 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Chapter 1. Methodology 1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical model and forecast 1.1.3. Industry insights and validation 1.1.4. Market definition and forecast parameters 1.2. Data sources 1.2.1. Primary 1.2.2. Secondary Chapter 2. Executive Summary 2.1. Bioreactor industry 3600 synopsis, 2013 - 2024 2.1.1. Business trends 2.1.2. Product trends 2.1.3. Technology trends 2.1.4. End use trends 2.1.5. Regional trends Table of Content:

6 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Chapter 3. Bioreactor Industry Insights 3.1. Industry segmentation 3.2. Industry landscape, 2013 – 2024 3.3. Industry ecosystem analysis 3.3.1. Distribution channel analysis 3.3.2. Vendor matrix 3.4. Industry impact forces 3.4.1. Growth drivers 3.4.1.1. Growing biopharmaceuticals and biologics industry 3.4.1.2. Technological advancements in bioreactor 3.4.1.3. Growing orphan drugs developments 3.4.1.4. Increasing demand for personalized medicines 3.4.2. Industry pitfalls & challenges 3.4.2.1. Low capacity of single use bioreactor 3.4.2.2. Concerns regarding extractables 3.5. Regulatory landscape 3.5.1. U.S. 3.5.2. Canada Table of Content:

7 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com 3.5.3. Germany 3.5.4. UK 3.5.5. China 3.6. Outsourcing landscape 3.7. Technology landscape 3.7.1. U.S. 3.7.2. Europe 3.8. Growth potential analysis 3.8.1. By Molecule 3.8.2. By Technology 3.9. Porter’s analysis 3.10. Bioreactor competitive landscape, 2016 3.10.1. Business overview 3.10.2. Revenue analysis 3.10.3. Product landscape 3.10.4. Strategy dashboard 3.11. PESTEL analysis Table of Content:

8 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On Bioreactor Market @ http://bit.ly/2rek6vB http://bit.ly/2rek6vB Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/141 https://www.gminsights.com/request-sample/detail/141 https://www.gminsights.com/request-sample/detail/49

9 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media:


Download ppt "© 2016 Global Market Insights, Inc. USA. All Rights Reserved Mammalian Cells Bioreactor Market to reach $1.5 bn by 2024"

Similar presentations


Ads by Google